TITLE

THROMBOLYSIS WITH FIBRINOLYSIN IN CEREBRAL ARTERIAL OCCLUSION; THE ROLE OF ANGIOGRAPHY

AUTHOR(S)
Sussman, Bernard J.; Fitch, Thomas S. P.
PUB. DATE
August 1959
SOURCE
Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p268
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Nine patients with demonstrable cerebral or carotid occlusions have been treated with fibrinolysin. The results of treatment have been interpreted on the basis of follow-up angiograms or postmortem studies. Favorable results marked by vascular clearing have been obtained in 4 cases. Three of these were embolic in nature. A partially favorable result was observed in 2 cases. Of the 3 apparent failures of therapy, only one could be established with certainty. This work remains conjectural and does not warrant conclusions at this time. The specific usefulness of fibrinolysin in embolic cerebral occlusions, however, is strongly suggested.
ACCESSION #
16388372

 

Related Articles

  • THROMBOLYSIS WITH FIBRINOLYSIN IN CEREBRAL ARTERIAL OCCLUSION. Sussman, Bernard J.; Fitch, Thomas S. P. // Angiology;May1961, Vol. 12 Issue 5, p169 

    Eleven patients with angiographically demonstrated cerebral or carotid occlusions were treated with fibrinolysin. Evidence of vascular clearing was obtained in 5 patients. Partial results were noted in 2 cases. The authors favor intracarotid administration of the enzyme. Clinical evaluation...

  • S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion. Foerch, C.; de Rochemont, R. du Mesnil; Singer, O.; Neumann-Haefelin, T.; Buchkremer, M.; Zanella, F. E.; Steinmetz, H.; Sitzer, M. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2003, Vol. 74 Issue 3, p322 

    Objectives: The astroglial protein S100B is a marker of cerebral tissue damage. This study investigated whether the serum kinetic of S100B may serve as a surrogate marker of successful clot lysis and early recanalisation (< 6 hours) in hyperacute proximal middle cerebral artery (MCA/M1)...

  • CT Angiography in an Acute Stroke Protocol: Correlation between Occlusion Site and Outcome of Intravenous Thrombolysis. PORELLI, S.; LEONARDI, M.; STAFA, A.; BARBARA, C.; PROCACCIANTI, G.; SIMONETTI, L. // Interventional Neuroradiology;Mar2013, Vol. 19 Issue 1, p87 

    Thrombolysis with intravenous rt-PA is the current therapy for acute ischemic stroke. Unlike other outcome factors, relatively little is known about the prognostic value of the occlusion site on treatment outcome. We compared the effectiveness and safety of intravenous thrombolysis in patients...

  • Cerebral angiographic findings in thromboangiitis obliterans. No, Young J.; Lee, Eun M.; Lee, Deok H.; Kim, Jong S. // Neuroradiology;Dec2005, Vol. 47 Issue 12, p912 

    Transient ischemic attacks (TIAs) or ischemic stroke may complicate thromboangiitis obliterans (TAO). However, there has been debate regarding the mechanism of ischemic stroke in TAO. We report the case of a patient with TAO who developed repeated TIAs. An angiogram showed multiple alternative...

  • Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. T Kharitonova // Journal of Neurology, Neurosurgery & Psychiatry;Mar2009, Vol. 80 Issue 3, p273 

    BACKGROUND AND PURPOSE: Hyperdense middle cerebral artery sign (HMCAS) on CT is a well known indication of thromboembolic arterial occlusion. Its disappearance after thrombolytic therapy is poorly described. Taking the rate of HMCAS disappearance as a surrogate for MCA recanalisation, its...

  • Parent Artery Occlusion for Intracranial Aneurysms. Lishan Cui; Qiang Peng; Wenbo Ha; Dexiang Zhou; Yang Xu // Interventional Neuroradiology;2009, Vol. 15 Issue 3, p309 

    Peripheral cerebral aneurysms are difficult to treat with preservation of the parent arteries. We report the clinical and angiographic outcome of 12 patients with cerebral aneurysms located peripherally. In the past five years, 12 patients, six females and six males, presented at our institution...

  • Massive Pulmonary Embolism: Short-Term Effects of Thrombolytic Treatment. Grau, E.; Fontcuberta, J.; Pagé, M. A.; Martinez, R.; Félez, J.; Net, A.; Rutllant, M. LI. // Angiology;Nov1986, Vol. 37 Issue 11, p832 

    This study assessed the short-term effects of thrombolytic treatment in 38 patients with massive pulmonary embolism. Thirty-two were treated with streptokinase and six with urokinase. Intrapulmonary artery instillation of fibrinolytic agents was utilized except in 3 patients. There was a marked...

  • EXPERIENCE WITH FIBRINOLYTIC THERAPY OF VASCULAR OCCLUSIVE DISEASE. Warner, W. L. // Vascular Surgery;Nov/Dec1977, Vol. 11 Issue 6, p364 

    1. There may well be a place for streptokinase therapy in selected patients with chronic arterial occlusion, but the emphasis should be on developing information on selection criteria. 2. Efficacy and safety have been established for the use of streptokinase in occluded AV cannulae, but this may...

  • Administration of Tissue Plasminogen Activator (tPA) during an Orthotopic Heart Transplant. Silverman, Richard; Fuhrman, Thomas; Barron, Michael E.; Ricci, Marco; Panos, Anthony; Sultan, Ali // Internet Journal of Anesthesiology;2010, Vol. 23 Issue 2, p9 

    A 56yr old female with nonischemic cardiomyopathy and a remote unsubstantited history of lupus anticoagulant presented for orthotopic heart transplant. During the decannulation, the cardiopulmonary pass pump showed signs of clot. Simultaneously Bispectral Analysis neurological monitoring...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics